Cleared Traditional

K101024 - KENZ CARDY302 MAX

K101024 is an FDA 510(k) clearance for KENZ CARDY302 MAX, manufactured by Suzuken Co., Ltd.. The device is a Class 2 Cardiovascular device with product code MWJ cleared through the Traditional 510(k) pathway after a 268-day FDA review.

K101024 · Suzuken Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
268d
Days
Class 2
Risk

K101024 is an FDA 510(k) clearance for the KENZ CARDY302 MAX. Classified as Electrocardiograph, Ambulatory (without Analysis) (product code MWJ), Class II - Special Controls.

Submitted by Suzuken Co., Ltd. (Richardson, US). The FDA issued a Cleared decision on January 6, 2011 after a review of 268 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K101024

510(k) Number K101024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 2010
Decision Date January 06, 2011
Days to Decision 268 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 125d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWJ Device Classification - Class 2, Special Controls

Product Code MWJ Electrocardiograph, Ambulatory (without Analysis)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWJ Electrocardiograph, Ambulatory (without Analysis)

All 63
Devices cleared under the same product code (MWJ) and FDA review panel - the closest regulatory comparables to K101024.
EZSLEEP SLEEP QUALITY RECORDER
K112573 · Platinum Team Co., Ltd. · Mar 2012
INTRICON DATRIX SIRONA EVENT/ HOLTER RECORDER
K112601 · Intricon Datrix Corporation · Nov 2011
MH1 MICROHOLTER RECORDER
K101969 · Exelys, LLC · Feb 2011
MODEL 950-12L HOLTER RECORDER WITHOUT ANALYSIS
K102723 · Memtec Corp. · Dec 2010
BTL-08 ECG RECORDER MODEL BTL-08 ECG LC PLUS, BTL-08 ECG LT PLUS
K100310 · BTL Industries, Inc. · Oct 2010
ACTIWAVE 1E, ACTIWAVE2E, ACTIWAVE2M, ACTIWAVE4E, ACTIWAVE CARDIO MODEL 08-514, 08-521, 08-536, 08-557, 08-603
K100266 · Camntech, Ltd. · Apr 2010
K101024 · KENZ CARDY302 MAX
Download PDF FDA Summary Suzuken Co., Ltd.